DE69431430T2 - Faktor XIII zur Behandlung von Hautwunden - Google Patents

Faktor XIII zur Behandlung von Hautwunden

Info

Publication number
DE69431430T2
DE69431430T2 DE69431430T DE69431430T DE69431430T2 DE 69431430 T2 DE69431430 T2 DE 69431430T2 DE 69431430 T DE69431430 T DE 69431430T DE 69431430 T DE69431430 T DE 69431430T DE 69431430 T2 DE69431430 T2 DE 69431430T2
Authority
DE
Germany
Prior art keywords
factor xiii
treatment
skin wounds
skin
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69431430T
Other languages
English (en)
Other versions
DE69431430D1 (de
Inventor
Naoko Kato
Takashi Ogawa
Shuji Kondo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Application granted granted Critical
Publication of DE69431430D1 publication Critical patent/DE69431430D1/de
Publication of DE69431430T2 publication Critical patent/DE69431430T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69431430T 1993-03-30 1994-03-02 Faktor XIII zur Behandlung von Hautwunden Expired - Lifetime DE69431430T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7139593 1993-03-30
PCT/IB1994/000040 WO1994022470A1 (en) 1993-03-30 1994-03-02 Factor xiii for treatment of skin wounds

Publications (2)

Publication Number Publication Date
DE69431430D1 DE69431430D1 (de) 2002-10-31
DE69431430T2 true DE69431430T2 (de) 2003-05-22

Family

ID=13459291

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69431430T Expired - Lifetime DE69431430T2 (de) 1993-03-30 1994-03-02 Faktor XIII zur Behandlung von Hautwunden

Country Status (7)

Country Link
EP (1) EP0691850B1 (de)
KR (1) KR100302935B1 (de)
AT (1) ATE224727T1 (de)
AU (1) AU674061B2 (de)
DE (1) DE69431430T2 (de)
ES (1) ES2182840T3 (de)
WO (1) WO1994022470A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4784693A (en) 1992-07-24 1994-02-14 Oklahoma Medical Research Foundation Blockade of protein c activation reduces microvascular surgical blood loss
IL125983A0 (en) * 1998-08-30 1999-04-11 Yeda Res & Dev Pharmaceutical composition comprising factor xiiia
AU2002360269B2 (en) 2001-10-09 2007-03-22 Zymogenetics, Inc. Method for inhibiting the formation of seromas using factor XIII
JP2005530768A (ja) 2002-05-09 2005-10-13 メディジーンズ 血漿または血清を含有した創傷治療用医薬組成物
JP2004075661A (ja) * 2002-06-18 2004-03-11 Shiseido Co Ltd 表皮基底膜ケアを特徴とする皮膚外用剤、皮膚基底膜構造形成促進剤および人工皮膚の製造方法
EP1566183A1 (de) * 2004-02-20 2005-08-24 ZLB Behring GmbH Verwendung vom Faktor XIII zur Stimulierung der Durchblutung von ischämischem Gewebe
US10391062B2 (en) 2008-04-21 2019-08-27 Novo Nordisk Healthcare Ag Dry transglutaminase composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
DE3751269T2 (de) * 1986-09-19 1995-09-14 Univ Washington Expression des biologisch aktiven Faktors XIII.
DE3808048A1 (de) * 1988-03-11 1989-09-21 Behringwerke Ag Verfahren zum affinitaetschromatografischen reinigen von faktor xiii
DE3829524A1 (de) * 1988-08-31 1990-03-01 Behringwerke Ag Verwendung von transglutaminasen als immunsuppressiva

Also Published As

Publication number Publication date
AU6155794A (en) 1994-10-24
EP0691850B1 (de) 2002-09-25
AU674061B2 (en) 1996-12-05
ATE224727T1 (de) 2002-10-15
WO1994022470A1 (en) 1994-10-13
KR100302935B1 (ko) 2001-11-30
ES2182840T3 (es) 2003-03-16
EP0691850A1 (de) 1996-01-17
KR960701657A (ko) 1996-03-28
DE69431430D1 (de) 2002-10-31

Similar Documents

Publication Publication Date Title
Nalbandian et al. Pluronic F‐127 gel preparation as an artificial skin in the treatment of third‐degree burns in pigs
DE69334145D1 (de) Terfenadin-Carboxylat und die Behandlung von Hautreizung
ID24901A (id) Metode pengobatan keadaan terkoagulasi tinggi atau defisiensi protein c yang diperoleh
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
JP3550685B2 (ja) 創傷治療剤
ATE131064T1 (de) Behandlung zur ermässigung von ödem und muskelschäden.
DE60018409D1 (de) Verwendung von antiseptika zur herstelllung von arzneimitteln zur prophylaxe und behandlung von infektionen und/ oder funktionellen gewebeumformungen im körperinneren
DE69431430D1 (de) Faktor XIII zur Behandlung von Hautwunden
WO1994017792A3 (en) Compositions and methods for transdermal drug delivery
US5024838A (en) Compositions for the treatment of skin injuries
KR930019224A (ko) 유산 위험 치료제
AU5643299A (en) Humic acid and its use in the treatment of various conditions
ATE171071T1 (de) Verfahren und zusammensetzungen zur verminderung von blutverlust
DE69921678D1 (de) Zusammensetzung enthaltend di- und trinatriumsalze von echinochrome zur behandlung von augenerkrankungen
CA2159609A1 (en) Factor xiii for treatment of skin wounds
DK1007085T3 (da) Anvendelse af væksthormon i præparater til behandling af insulin-resistens i hjertet
Prescott Doxil offers hope to KS sufferers
EP0880967A3 (de) Nephroprotektive Arzneimittel
RU2093093C1 (ru) Способ лечения глубоких отморожений пальцев кисти
RU2003344C1 (ru) Способ лечени ожоговой болезни
US20190209639A1 (en) Ointment for burn
Krizek Wound and reconstructive problems in advanced disease
RU2191004C2 (ru) Способ консервативного лечения отморожения конечностей
Kharitonov et al. Treatment of suppurative wounds of soft tissues with colocyl and its combination with proteolytic enzymes
Sullivan et al. Surgical Pearl: Punch technique to improve granulation over exposed tendons in chronic wounds

Legal Events

Date Code Title Description
8364 No opposition during term of opposition